Cargando…
Evaluation of bioactive compounds from Boswellia serrata against SARS-CoV-2
With the COVID-19 pandemic still wreaking havoc worldwide, new variants being discovered every month in some parts of the globe due to the mutating nature of the virus. There is no specific solution for this highly transmissible disease. In search of a lead molecule for the discovery and development...
Autores principales: | Roy, Arpita, Menon, Tarunya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595075/ https://www.ncbi.nlm.nih.gov/pubmed/34803247 http://dx.doi.org/10.1007/s42535-021-00318-7 |
Ejemplares similares
-
Boswellia serrata Extract as an Antibiofilm Agent against Candida spp.
por: Jaroš, Petr, et al.
Publicado: (2022) -
Development, Analytical Characterization, and Bioactivity Evaluation of Boswellia serrata Extract-Layered Double Hydroxide Hybrid Composites
por: Cometa, Stefania, et al.
Publicado: (2023) -
Boswellia Serrata, A Potential Antiinflammatory Agent: An Overview
por: Siddiqui, M. Z.
Publicado: (2011) -
Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis)
por: Gupta, P. K., et al.
Publicado: (2011) -
Management strategies for knee osteoarthritis: Aflapin(®) (Boswellia serrata extract)
por: Suva, Manoj A., et al.
Publicado: (2017)